ArticleACS omega2026
Chitosan-Starch Biocomposite for Enhanced Curcumin Delivery: Kinetic Modeling of pH and Ionic Strength Responsive Release and Evaluation of Biological Efficacy.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A drug delivery system composed of chitosan and starch was used to deliver curcumin effectively by enhancing its pharmacokinetic properties. The sustained release of the synthesized delivery system was evaluated using a kinetic modeling approach along with its biological efficacy. The SEM analysis confirmed the coupling of starch and chitosan and loading of curcumin into the matrix during synthesis. Crystallographic orientation of the delivery system was confirmed by XRD, and the FT-IR data confirmed the successful loading of curcumin. TG analysis indicated that the increment in decomposition temperature of the composite is due to the incorporation of curcumin into the composite. BET analysis revealed the reduction in the BET surface area and pore volume in the synthesized composite, confirming successful loading. The IC
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.